company background image
FONR

FONARNasdaqCM:FONR Stock Report

Market Cap

US$111.9m

7D

0.2%

1Y

-13.2%

Updated

27 Nov, 2021

Data

Company Financials
FONR fundamental analysis
Snowflake Score
Valuation5/6
Future Growth0/6
Past Performance4/6
Financial Health6/6
Dividends0/6

FONR Stock Overview

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States.

FONAR Competitors

Cutera

NasdaqGS:CUTR

US$715.8m

Misonix

NasdaqGM:MSON

US$462.5m

IRIDEX

NasdaqGM:IRIX

US$103.4m

Siemens

XTRA:SIE

€115.9b

Price History & Performance

Summary of all time highs, changes and price drops for FONAR
Historical stock prices
Current Share PriceUS$16.74
52 Week HighUS$20.50
52 Week LowUS$14.93
Beta0.99
1 Month Change3.98%
3 Month Change0.84%
1 Year Change-13.22%
3 Year Change-24.01%
5 Year Change-14.37%
Change since IPO2.03%

Recent News & Updates

Oct 11

FONAR Corporation: Finally Closing In On A Multi-Year Bottom

Revenue almost hits $90 million & EBIT grows by 25% to surpass $17 million in Fonar's latest fiscal year. The recent fourth quarter (ending June 2021) reported almost 48,000 scans which certainly is a bullish trend. Fonar is not resting on its laurels. Four major projects in the works for fiscal 2022. This should drive sales, earnings and the share price higher over time.

Shareholder Returns

FONRUS Medical EquipmentUS Market
7D0.2%-4.5%-2.7%
1Y-13.2%13.4%21.3%

Return vs Industry: FONR underperformed the US Medical Equipment industry which returned 13.4% over the past year.

Return vs Market: FONR underperformed the US Market which returned 21.3% over the past year.

Price Volatility

Is FONR's price volatile compared to industry and market?
FONR volatility
FONR Average Weekly Movement4.7%
Medical Equipment Industry Average Movement7.2%
Market Average Movement6.0%
10% most volatile stocks in US Market15.0%
10% least volatile stocks in US Market2.3%

Stable Share Price: FONR is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: FONR's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1978495Tim Damadianhttps://www.fonar.com

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates through two segments, Medical Equipment segment, and Physician Management and Diagnostic services segment. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down.

FONAR Fundamentals Summary

How do FONAR's earnings and revenue compare to its market cap?
FONR fundamental statistics
Market CapUS$111.85m
Earnings (TTM)US$11.07m
Revenue (TTM)US$92.68m

10.1x

P/E Ratio

1.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
FONR income statement (TTM)
RevenueUS$92.68m
Cost of RevenueUS$48.70m
Gross ProfitUS$43.98m
ExpensesUS$32.91m
EarningsUS$11.07m

Last Reported Earnings

Sep 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)1.66
Gross Margin47.45%
Net Profit Margin11.94%
Debt/Equity Ratio0.2%

How did FONR perform over the long term?

See historical performance and comparison

Valuation

Is FONAR undervalued compared to its fair value and its price relative to the market?

37.4%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: FONR ($16.74) is trading below our estimate of fair value ($26.75)

Significantly Below Fair Value: FONR is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: FONR is good value based on its PE Ratio (10.1x) compared to the US Medical Equipment industry average (45.2x).

PE vs Market: FONR is good value based on its PE Ratio (10.1x) compared to the US market (17.2x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate FONR's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: FONR is good value based on its PB Ratio (0.8x) compared to the US Medical Equipment industry average (3.7x).


Future Growth

How is FONAR forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

15.0%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as FONAR has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has FONAR performed over the past 5 years?

-15.5%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: FONR has high quality earnings.

Growing Profit Margin: FONR's current net profit margins (11.9%) are higher than last year (8.4%).


Past Earnings Growth Analysis

Earnings Trend: FONR's earnings have declined by 15.5% per year over the past 5 years.

Accelerating Growth: FONR's earnings growth over the past year (55.6%) exceeds its 5-year average (-15.5% per year).

Earnings vs Industry: FONR earnings growth over the past year (55.6%) exceeded the Medical Equipment industry 51.2%.


Return on Equity

High ROE: FONR's Return on Equity (11.2%) is considered low.


Financial Health

How is FONAR's financial position?


Financial Position Analysis

Short Term Liabilities: FONR's short term assets ($109.4M) exceed its short term liabilities ($16.2M).

Long Term Liabilities: FONR's short term assets ($109.4M) exceed its long term liabilities ($32.5M).


Debt to Equity History and Analysis

Debt Level: FONR has more cash than its total debt.

Reducing Debt: FONR's debt to equity ratio has reduced from 4.7% to 0.2% over the past 5 years.

Debt Coverage: FONR's debt is well covered by operating cash flow (7354.2%).

Interest Coverage: FONR earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is FONAR current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate FONR's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate FONR's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if FONR's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if FONR's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of FONR's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

5.8yrs

Average management tenure


CEO

Tim Damadian (57 yo)

5.75yrs

Tenure

US$155,800

Compensation

Mr. Timothy R. Damadian, also known as Tim, has been Chief Executive Officer and President of Fonar Corp. since February 11, 2016. From 2010 to 2016, he served as an independent consultant. Mr. Damadian be...


Leadership Team

Experienced Management: FONR's management team is seasoned and experienced (5.8 years average tenure).


Board Members

Experienced Board: FONR's board of directors are seasoned and experienced ( 21.8 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

FONAR Corporation's employee growth, exchange listings and data sources


Key Information

  • Name: FONAR Corporation
  • Ticker: FONR
  • Exchange: NasdaqCM
  • Founded: 1978
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: US$111.854m
  • Shares outstanding: 6.68m
  • Website: https://www.fonar.com

Number of Employees


Location

  • FONAR Corporation
  • 110 Marcus Drive
  • Melville
  • New York
  • 11747
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/11/27 23:11
End of Day Share Price2021/11/26 00:00
Earnings2021/09/30
Annual Earnings2021/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.